Genomic diversity of mumps virus and global distribution of the 12 genotypes

Reviews in Medical Virology

Volumn 25, Issue 2, 2015, Pages 85-101

  Jin, Li ^a   Örvell, Claes ^b   Myers, Richard ^a   Rota, Paul A ^c   Nakayama, Tetsuo ^d   Forcic, Dubravko ^e   Hiebert, Joanne ^f   Brown, Kevin E ^a  

^a PUBLIC HEALTH ENGLAND   (United Kingdom)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d KITASATO UNIVERSITY   (Japan)

^e UNIVERSITY OF ZAGREB   (Croatia)

^f PUBLIC HEALTH AGENCY OF CANADA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

MEMBRANE PROTEIN; HN PROTEIN; SMALL HYDROPHOBIC PROTEIN, MUMPS VIRUS; VIRAL PROTEIN; VIRUS RNA;

DATA ANALYSIS; EVOLUTION; F GENE; GENE; GENE SEQUENCE; GENETIC VARIABILITY; GENOTYPE; GEOGRAPHIC DISTRIBUTION; HN GENE; HUMAN; MICROBIAL DIVERSITY; MUMPS VIRUS; MUMPS VIRUS GENOTYPE A; MUMPS VIRUS GENOTYPE B; MUMPS VIRUS GENOTYPE C; MUMPS VIRUS GENOTYPE D; MUMPS VIRUS GENOTYPE E; MUMPS VIRUS GENOTYPE F; MUMPS VIRUS GENOTYPE G; MUMPS VIRUS GENOTYPE H; MUMPS VIRUS GENOTYPE I; MUMPS VIRUS GENOTYPE J; MUMPS VIRUS GENOTYPE K; MUMPS VIRUS GENOTYPE L; MUMPS VIRUS GENOTYPE M; MUMPS VIRUS GENOTYPE N; NONHUMAN; REVIEW; SEQUENCE ANALYSIS; VIRUS GENOME; VIRUS ISOLATION; CLASSIFICATION; CLUSTER ANALYSIS; DNA SEQUENCE; GENETIC VARIATION; GENETICS; HEALTH; ISOLATION AND PURIFICATION; MOLECULAR GENETICS; MUMPS; PHYLOGEOGRAPHY; SEQUENCE HOMOLOGY; SPATIOTEMPORAL ANALYSIS; VIROLOGY;

CLUSTER ANALYSIS; GENETIC VARIATION; GENOME, VIRAL; GENOTYPE; GLOBAL HEALTH; HN PROTEIN; HUMANS; MOLECULAR SEQUENCE DATA; MUMPS; MUMPS VIRUS; PHYLOGEOGRAPHY; RNA, VIRAL; SEQUENCE ANALYSIS, DNA; SEQUENCE HOMOLOGY; SPATIO-TEMPORAL ANALYSIS; VIRAL PROTEINS;

EID: 84924047565     PISSN: 10529276     EISSN: 10991654     Source Type: Journal    
DOI: 10.1002/rmv.1819     Document Type: Review

References (86)

1. Gershon AA. Chickenpox, measles and mumps. In Infectious diseases of the fetus and newborn infant, Remington JS, Klein JO (eds). WB Saunders Company: Philadephia, 1995. 565-618.
2. Knowles W, Jin L. Rubulavirus: Mumps Virus. In Topley and Wilson-Microbiology and Microbial Infections, Mahy BWJ, ter Meulen V (eds). Hodder Arnold: London, 2005; 744-762.
3. Johnson CD, Goodpasture E. An investigation of the etiology of mumps. J Exp Med 1934; 59(1):1-19.
4. Cui A, Brown DW, Xu W, Jin L. Genetic variation in the HN and SH genes of mumps viruses: a comparison of strains from mumps cases with and without neurological symptoms. PLoS One 2013; 8(4):e61791.
5. WHO. Global status of mumps immunization and surveillance. Weekly Epidemiological Record 2005; 84: 418-424.
6. WHO. Mumps virus nomenclature update: 2012. Weekly Epidemiological Record 2013; 87[22]: 217-224.
7. Yung CF, Andrews N, Bukasa A, Brown KE, Ramsay M. Mumps complications and effects of mumps vaccination, England and Wales, 2002-2006. Emerg Infect Dis 2011; 17(4): 661-667.
8. Jin L, Brown DW, Litton PA, White JM. Genetic diversity of mumps virus in oral fluid specimens: application to mumps epidemiological study. J Infect Dis 2004;189(6): 1001-1008.
9. Jin L, Vyse A, Brown DW. The role of RT-PCR assay of oral fluid for diagnosis and surveillance of measles, mumps and rubella. Bull World Health Organ 2002; 80(1): 76-77.
10. Carbone KM, Rubin S. Mumps virus. In Fields Virology, Knipe DM, Howley PM (eds). Lippincott Williams & Wilkins: Philadelphia, 2007; 1527-1550.
11. Savage E, Ramsay M, White J, Beard S, Lawson H, Hunjan R, et al. Mumps outbreaks across England and Wales in 2004: observational study. BMJ 2005; 330(7500): 1119-1120.
12. Peltola H, Kulkarni PS, Kapre SV, Paunio M, Jadhav SS, Dhere RM. Mumps outbreaks in Canada and the United States: time for new thinking on mumps vaccines. Clin Infect Dis 2007; 45(4): 459-466.
13. Afzal MA, Dussupt V, Minor PD, Pipkin PA, Fleck R, Hockley DJ, et al. Assessment of mumps virus growth on various continuous cell lines by virological, immunological, molecular and morphological investigations. J Virol Methods 2005; 126(1-2): 149-156.
14. Vaidya SR, Brown DW, Jin L, Samuel D, Andrews N, Brown KE. Development of a focus reduction neutralization test (FRNT) for detection of mumps virus neutralizing antibodies. J Virol Methods 2010; 163(1): 153-156.
15. Jin L, Richards A, Brown DW. Development of a dual target-PCR for detection and characterization of measles virus in clinical specimens. Mol Cell Probes 1996; 10: 191-200.
16. Jin L, Beard S, Brown DW. Genetic heterogeneity of mumps virus in the United Kingdom: identification of two new genotypes. J Infect Dis 1999; 180(3): 829-833.
17. Jin L, Beard S, Hale A, Knowles W, Brown DW. The genomic sequence of a contemporary wild-type mumps virus strain. Virus Res 2000; 70(1-2): 75-83.
18. Drexler JF, Corman VM, Muller MA, Maganga GD, Vallo P, Binger T, et al. Bats host major mammalian paramyxoviruses. Nature Communications 2012; 3(796): 1-12.
19. Cui A, Myers R, Xu W, Jin L. Analysis of the genetic variability of the mumps SH gene in viruses circulating in the UK between 1996 and 2005. Infect Genet Evol 2009; 9(1): 71-80.
20. Takeuchi K, Tanabayashi K, Hishiyama M, Yamada A. The mumps virus SH protein is a membrane protein and not essential for virus growth. Virology 1996; 225(1): 156-162.
21. Malik T, Shegogue CW, Werner K, Ngo L, Sauder C, Zhang C, et al. Discrimination of mumps virus small hydrophobic gene deletion effects from gene translation effects on virus virulence. J Virol 2011; 85(12): 6082-6085.
22. Tecle T, Johansson B, Jejcic A, Forsgren M, Orvell C. Characterization of three co-circulating genotypes of the small hydrophobic protein gene of mumps virus. J Gen Virol 1998; 79(12): 2929-2937.
23. Lim CS, Chan KP, Goh KT, Chow VT. Hemagglutinin-neuraminidase sequence and phylogenetic analyses of mumps virus isolates from a vaccinated population in Singapore. J Med Virol 2003; 70(2): 287-292.
24. Young DF, Galiano MC, Lemon K, Chen YH, Andrejeva J, Duprex WP, et al. Mumps virus Enders strain is sensitive to interferon (IFN) despite encoding a functional IFN antagonist. J Gen Virol 2009; 90(11): 2731-2738.
25. Liang Y, Ma S, Yang Z, Liu L, Wang L, Wang J, et al. Immunogenicity and safety of a novel formalin-inactivated and alum-adjuvanted candidate subunit vaccine for mumps. Vaccine 2008; 26(33): 4276-4283.
26. Liang Y, Ma S, Liu L, Zhao H, Wang L, Jiang L, et al. Identification and development of a promising novel mumps vaccine candidate strain. Microbes Infect 2010; 12(14-15): 1178-1187.
27. Orvell C, Alsheikhly AR, Kalantari M, Johansson B. Characterization of genotype-specific epitopes of the HN protein of mumps virus. J Gen Virol 1997; 78(12): 3187-3193.
28. Tecle T, Bottiger B, Orvell C, Johansson B. Characterization of two decades of temporal co-circulation of four mumps virus genotypes in Denmark: identification of a new genotype. J Gen Virol 2001; 82(2675): 2680.
29. Rubin SA, Pletnikov M, Taffs R, Snoy PJ, Kobasa D, Brown EG, et al. Evaluation of a neonatal rat model for prediction of mumps virus neurovirulence in humans. J Virol 2000; 74(5382): 5384.
30. Rubin SA, Pletnikov M, Li Z, Vanderzanden J, Mauldin J, Sauder C, et al. Changes in mumps virus gene sequence associated with variability in neurovirulent phenotype. J Virol 2003; 77: 11616-11624.
31. Rafiefard F, Johansson B, Tecle T, Orvell C. Characterization of mumps virus strains with varying neurovirulence. Scand J Infect Dis 2005; 37(5): 330-337.
32. Kulkarni-Kale U, Ojha J, Manjari GS, Deobagkar DD, Mallya AD, Dhere RM, et al. Mapping antigenic diversity and strain specificity of mumps virus: a bioinformatics approach. Virology 2007; 359(2): 436-446.
33. Ivancic-Jelecki J, Santak M, Forcic D. Variability of hemagglutinin-neuraminidase and nucleocapsid protein of vaccine and wild-type mumps virus strains. Infect Genet Evol 2008; 8(5): 603-613.
34. Shah D, Vidal S, Link MA, Rubin SA, Wright KE. Identification of genetic mutations associated with attenuation and changes in tropism of Urabe mumps virus. J Med Virol 2009; 81(1): 130-138.
35. Šantak M, Lang-Balija M, Ivancic-Jelecki J, Košutic-Gulija T, Ljubin-Sternak S, Forcic D. Antigenic differences between vaccine and circulating wild-type mumps viruses decreases neutralization capacity of vaccine-induced antibodies. Epidemiol Infect 2013; 141(6): 1298-1309.
36. Saito H, Takahashi Y, Harata S, Tanaka K, Sato H, Yamada A, et al. Cloning and characterization of the genomic RNA sequence of the mumps virus strain associated with a high incidence of aseptic meningitis. Microbiol Immunol 1998; 42(2): 133-137.
37. Saika S, Kidokoro M, Ohkawa T, Aoki A, Suzuki K. Pathogenicity of mumps virus in the marmoset. J Med Virol 2002;66(1):115-122.
38. Sauder CJ, Zhang CX, Ngo L, Werner K, Duprex WP, Malik T, et al. Gene-specific contributions to mumps virus neurovirulence and neuroattenuation. J Virol 2011; 85(14): 7059-7069.
39. Tanabayashi K, Takeuchi K, Okazaki K, Hishiyama M, Yamada A. Identification of an amino acid that defines the fusogenicity of mumps virus. J Virol 1993; 67(5): 2928-2931.
40. Tanabayashi K, Takeuchi K, Hishiyama M, Yamada A. Effect on fusion induction of point mutations introduced into the F protein of mumps virus. Virology 1994; 204(2): 851-853.
41. Tecle T, Johansson B, Yun Z, Orvell C. Antigenic and genetic characterization of the fusion (F) protein of mumps virus strains. Arch Virol 2000; 145(6): 1199-1210.
42. Uchida K, Shinohara M, Shimada S, Segawa Y, Kimura K, Hoshino Y. Characterization of the F gene of contemporary mumps virus strains isolated in Japan. Microbiol Immunol 2003; 47(2): 167-172.
43. Kilham L. Isolation of mumps virus from the blood of a patient. Proc Soc Exp Biol Med 1948; 69(1): 99.
44. Young ML, Dickstein B, Weibel RE, Stokes J Jr, Buynak EB, Hilleman MR. Experiences with Jeryl Lynn strain live attenuated mumps virus vaccine in a pediatric outpatient clinic. Pediatrics 1967; 40(5): 798-803.
45. Afzal MA, Pickford AR, Forsey T, Heath AB, Minor PD. The Jeryl Lynn vaccine strain of mumps virus is a mixture of two distinct isolates. J Gen Virol 1993;74(Pt 5): 917-920.
46. Afzal MA, Buchanan J, Heath AB, Minor PD. Clustering of mumps virus isolates by SH gene sequence only partially reflects geographical origin. Arch Virol 1997; 142(2): 227-238.
47. Palacios G, Jabado O, Cisterna D, de Ory F, Renwick N, Echevarria JE, et al. Molecular identification of mumps virus genotypes from clinical samples: standardized method of analysis. J Clin Microbiol 2005; 43(4): 1869-1878.
48. Echevarria JE, Castellanos A, Sanz JC, Perez C, Palacios G, Martinez M, et al. Circulation of mumps virus genotypes in Spain from 1996 to 2007. J Clin Microbiol 2010; 48(4): 1245-1254.
49. Sugiura A, Yamada A. Aseptic meningitis as a complication of mumps vaccination. Pediatr Infect Dis J 1991; 10(3): 209-213.
50. Kimura M, Kuno-Sakai H, Yamazaki S, Yamada A, Hishiyama M, Oya A, et al. Adverse events associated with MMR vaccines in Japan. Acta Paediatr Jpn 1996; 38(3): 205-211.
51. Inou Y, Nakayama T, Yoshida N, Uejima H, Yuri K, Kamada M, et al. Molecular epidemiology of mumps virus in Japan and proposal of two new genotypes. J Med Virol 2004; 73(1): 97-104.
52. Uchida K, Shinohara M, Shimada S, Segawa Y, Hoshino Y. Characterization of mumps virus isolated in saitama prefecture, Japan, by sequence analysis of the SH gene. Microbiol Immunol 2001; 45(12): 851-855.
53. Afzal MA, Buchanan J, Dias JA, Cordeiro M, Bentley ML, Shorrock CA, et al. RT-PCR based diagnosis and molecular characterisation of mumps viruses derived from clinical specimens collected during the 1996 mumps outbreak in Portugal. J Med Virol 1997 Aug; 52(4): 349-353.
54. Atrasheuskaya AV, Kulak MV, Rubin S, Ignatyev GM. Mumps vaccine failure investigation in Novosibirsk, Russia, 2002-2004. Clin Microbiol Infect 2007; 13(7): 670-676.
55. Santak M, Kosutic-Gulija T, Tesovic G, Ljubin-Sternak S, Betica-Radic L, Forcic D. Mumps virus strains isolated in Croatia in 1998 and 2005: Genotyping and putative antigenic relatedness to vaccine strains. J Med Virol 2006; 78(5): 638-643.
56. Tecle T, Mickiene A, Johansson B, Lindquist L, Orvell C. Molecular characterisation of two mumps virus genotypes circulating during an epidemic in Lithuania from 1998 to 2000. Arch Virol 2002; 147(2): 243-253.
57. Van Den Bosch CA, Cohen B, Walters T, Jin L. Mumps outbreak confined to a religious community. Euro Surveill 2000; 5(5): 58-60.
58. Vaidya SR, Chowdhury DT, Kumbhar NS, Tomar R, Kamble MB, Kazi MI. Circulation of TwoMumpsVirus Genotypes in an Unimmunized Population in India. J Med Virol 2013; 85(8): 426-432.
59. Ivancic J, Forcic D, Gulija TK, Zgorelec R, Repalust L, Baricevic M, et al. Genetic characterization of a mumps virus isolate during passaging in the amniotic cavity of embryonated chicken eggs. Virus Res 2004; 99(2): 121-129.
60. Santos CL, Ishida MA, Foster PG, Sallum MA, Borges DB, Correa KO, et al. Detection of a new mumps virus genotype during parotitis epidemic of 2006-2007 in the state of Sao Paulo, Brazil. J Med Virol 2008; 80(2): 323-329.
61. Jin L, Rima B, Brown D, Orvell C, T Tecle T, Afzal M, et al. Proposal for genetic characterisation of wild-type mumps strains: preliminary standardisation of the nomenclature. Arch Virol 2005; 150(1903): 1909.
62. Cohen BJ, Jin L, Brown DW, Kitson M. Infection with wild-type mumps virus in army recruits temporally associated with MMR vaccine. Epidemiol Infect 1999; 123(2): 251-255.
63. Cohen C, White JM, Savage EJ, Glynn JR, Choi Y, Andrews N, et al. Vaccine effectiveness estimates, 2004-2005 mumps outbreak, England. Emerg Infect Dis 2007; 13: 12-17.
64. Whelan J, van Binnendijk R, Greenland K, Fanoy E, Khargi M, Yap K, et al. Ongoing mumps outbreak in a student population with high vaccination coverage, Netherlands, 2010. Euro Surveill 2010; 15(17): 19554.
65. Carr MJ, Moss E, Waters A, Dean J, Jin L, Coughlan S, et al. Molecular epidemiological evaluation of the recent resurgence in mumps virus infections in Ireland. J Clin Microbiol 2010; 48(9): 3288-3294.
66. Anis E, Grotto I, Moerman L, Warshavsky B, Slater PE, Lev B. Mumps outbreak in Israel's highly vaccinated society: are two doses enough? Epidemiol Infect 2012; 140(3): 439-446.
67. Otto W, Mankertz A, Santibanez S, Saygili H, Wenzel J, Jilg W, et al. Ongoing outbreak of mumps affecting adolescents and young adults in Bavaria, Germany, August to October 2010. Euro Surveill 2010; 15(50): 19748.
68. Bernard H, Schwarz NG, Melnic A, Bucov V, Caterinciuc N, Pebody RG, et al. Mumps outbreak ongoing since October 2007 in the Republic of Moldova. Euro Surveill 2008; 13(13): 8079.
69. Kuzmanovska G, Polozhani A, Mikik V, Stavridis K, Aleksoski B, Cvetanovska Z, et al. Mumps outbreak in the former Yugoslav Republic of Macedonia, January 2008-June 2009: epidemiology and control measures. Euro Surveill 2010; 15(23): 19586.
70. Hukic M, Ravlija J, Dedeic Ljubovic A, Moro A, Arapcic S, Muller CP, et al. Ongoing large mumps outbreak in the Federation of Bosnia and Herzegovina, Bosnia and Herzegovina, December 2010 to July 2011. Euro Surveill 2011; 16(35): 19959.
71. Watson-Creed G, Saunders A, Scott J, Lowe L, Pettipas J, Hatchette TF. Two successive outbreaks of mumps in Nova Scotia among vaccinated adolescents and young adults. Canadian Medical Association Journal 2006; 175(5): 483-488.
72. Rota JS, Turner JC, Yost-Daljev MK, Freeman M, Toney DM, Meisel E, et al. Investigation of a mumps outbreak among university students with two measles-mumps-rubella (MMR) vaccinations, Virginia, September-December 2006. J Med Virol 2009; 81(10): 1819-1825.
73. Strohle A, Bernasconi C, Germann D. A new mumps virus lineage found in the 1995 mumps outbreak in western Switzerland identified by nucleotide sequence analysis of the SH gene. Arch Virol 1996; 141(3-4): 733-741.
74. Lee JY, Na BK, Kim JH, Lee JS, Park JW, Shin GC, et al. Regional outbreak of mumps due to genotype H in Korea in 1999. J Med Virol 2004; 73(1): 85-90.
75. Montes M, Cilla G, Artieda J, Vicente D, Basterretxea M. Mumps outbreak in vaccinated children in Gipuzkoa (Basque Country), Spain. Epidemiol Infect 2002; 129(3): 551-556.
76. Agafonov AP, Neverov AA, Kameneva SN, Saraev DV, Ginko ZI, Blinov VM, et al. Isolation, genotyping and analysis of the complete nucleotide sequence of mumps virus Siberian strain. Epidemiol Vakcinoprofil 2007; 5: 34-42.
77. Hindiyeh MY, Aboudy Y, Wohoush M, Shulman LM, Ram D, Levin T, et al. Characterization of large mumps outbreak among vaccinated Palestinian refugees. J Clin Microbiol 2009; 47(3): 560-565.
78. Akcali A, Yilmaz N, Uyar Y, Ertek M, Buzgan T. Genotyping of mumps virus circulating in Turkey in the 2006-2007 winter season. Arch Virol 2009; 154(11): 1807-1812.
79. Kidokoro M, Tuul R, Komase K, Nymadawa P. Characterization of mumps viruses circulating in Mongolia: identification of a novel cluster of genotype H. J Clin Microbiol 2011; 49(5): 1917-1925.
80. Kashiwagi Y, Takami T, Mori T, Nakayama T. Sequence analysis of F, SH, and HN genes among mumps virus strains in Japan. Arch Virol 1999; 144(3): 593-599.
81. Reid F, Hassan J, Irwin F, Waters A, Hall W, Connell J. Epidemiologic and diagnostic evaluation of a recent mumps outbreak using oral fluid samples. J Clin Virol 2008; 41(2): 134-137.
82. Wu L, Bai Z, Li Y, Rima BK, Afzal MA. Wild type mumps viruses circulating in China establish a new genotype. Vaccine 1998; 16(2-3): 281-285.
83. Shi H, Liu L, Ma S, Chen J, Che Y, Wang J, et al. Molecular epidemiology of mumps virus strains circulating in south-west China from 2007 to 2009. J Med Microbiol 2011; 60(10): 1496-1501.
84. Saito H, Takahashi Y, Harata S, Tanaka K, Sano T, Suto T, et al. Isolation and characterization of mumps virus strains in a mumps outbreak with a high incidence of aseptic meningitis. Microbiol Immunol 1996; 40(4): 271-275.
85. Lee JY, Kim YY, Shin GC, Na BK, Lee JS, Lee HD, et al. Molecular characterization of two genotypes of mumps virus circulated in Korea during 1998-2001. Virus Res 2003; 97(2): 111-116.
86. Ivancic J, Gulija TK, Forcic D, Baricevic M, Jug R, Mesko-Prejac M, et al. Genetic characterization of L-Zagreb mumps vaccine strain. Virus Res 2005; 109(1): 95-105.